Inception is a Life Science focused venture capital fund, investing from inception to exit across four main R&D areas: drug development, medtech, diagnostics and digital health.
We are looking for the next cure for cancer or chronic diseases, the new pacemaker or digital solutions in the healthcare space.
solutions to unmet
Disruptive innovation in healthcare is needed. Venture capital in Life Sciences has been a pillar to innovation in health care. Most innovative molecules or devices that were introduced in the market over the last decades came from small venture capital backed companies.
Inception brings projects from academic settings into startups and to patients.
Investing in teams and startups in Southern Europe, with a focus in Portugal.
We invest in technologies and startups across four areas:
- Drug Development
- Digital Health
- Early Stage
- Seed & Series A
The model behind Life Sciences investing is well established, VC funds act as innovation backers. With the biotech and medtech fields maturing there is now accumulated experience and data that allows risk assessment at each step of the development process and, with it, make scientifically driven investments to disperse risk and maximize returns.
Our team sources top tier technologies, startups and teams as potential targets for investment. This proprietary dealflow is ensured by partnerships with a network of leading R&D centers and top tier accelerators in the field, granting Inception preferential access.
Our portfolio companies are embedded in an ecosystem adding value towards their growth and internationalization. We leverage the unique experience of our partners in the field by having them act as managers and the ecosystem supports companies across an array of activities, such as company incorporation, and access to state-of-the-art equipment, knowledge and word-class experts.